Last update 20 Dec 2025

EVER-4010001

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EVER 4010001, EVER4010001
Target
FGFR4
Action
antagonists
Mechanism
FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmLocally Advanced Malignant Solid Neoplasm
Originator Organization
EverNov Medicines (Zhuhai Hengqin) Co. Ltd.
Active Organization-
Inactive Organization
EverNov Medicines (Zhuhai Hengqin) LimitedEverNov Medicines (Zhuhai Hengqin) Co. Ltd.
License Organization-
Drug Highest PhaseSuspendedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with EVER-4010001
NCT04699643
/ Unknown statusPhase 1/2
A Phase I/II Study of FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors With Dose Escalation and Expansion to Selected Indications
100 Clinical Results associated with EVER-4010001
Login to view more data
100 Translational Medicine associated with EVER-4010001
Login to view more data
100 Patents (Medical) associated with EVER-4010001
Login to view more data
100 Deals associated with EVER-4010001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
China
EverNov Medicines (Zhuhai Hengqin) Limited
31 Jul 2020
Locally Advanced Malignant Solid NeoplasmPhase 2
China
EverNov Medicines (Zhuhai Hengqin) Co. Ltd.
30 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free